Literature DB >> 702245

Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants.

R B Cotton, M T Stahlman, H W Bender, T P Graham, W Z Catterton, I Kovar.   

Abstract

As a result of randomized assignment, 15 preterm infants weighing 1,500 gm or less at birth and who had a symptomatic PDA were treated according to a medical management protocol, and ten according to an early surgical closure protocol. All infants required mechanical ventilation at the time of study entry, which was one week after birth. Birth weight, gestational age, age at onset of congestive failure, age at study entry, and the initial morbidity of members of the two groups were similar. The nine surviving infants managed according to the surgical closure protocol were weaned from mechanical ventilation sooner, had a decreased need for digoxin and furosemide, achieved gastrointestinal function sooner, and had a smaller hospital bill than the 12 survivors of the medical management group. These results indicate that infants with a symptomatic PDA still requiring mechanical ventilation at one week after birth will benefit from surgical closure of the ductus at that time.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702245     DOI: 10.1016/s0022-3476(78)80910-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

1.  Double aortic arch with patent ductus arteriosus in a premature infant: an unusual vascular malformation.

Authors:  C H Gumbiner; D M Howell; R L Kingry; R E Prager
Journal:  Tex Heart Inst J       Date:  1983-12

Review 2.  Patent ductus arteriosus: evidence for and against treatment.

Authors:  Ronald I Clyman; Nancy Chorne
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

3.  Day case ligation of patent ductus arteriosus in preterm infants: a 10 year review.

Authors:  C R Satur; D R Walker; D F Dickinson
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 4.  A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.

Authors:  Ronald L Thomas; Graham C Parker; Bart Van Overmeire; Jacob V Aranda
Journal:  Eur J Pediatr       Date:  2004-12-10       Impact factor: 3.183

5.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

Review 6.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 7.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.

Authors:  Chuan-Zhong Yang; Jiun Lee
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

9.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Patent ductus arteriosus in infants of low birth weight.

Authors:  D R Smith; D H Cook; T Izukawa; P M Olley; P R Swyer; R D Rowe
Journal:  Can Med Assoc J       Date:  1980-10-18       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.